#TeamMyllia
LightNews LightNews
mylliabio.bsky.social
People of #TeamMyllia
Our most recent group picture features almost everyone in the team, reflecting how international, multifaceted and diverse our company has become.
Learn more about us: myllia.com/about-us/
Team Myllia 2026
July 9, 2026 at 12:08 PM
henrik-hs.bsky.social
Looking forward to representing @mylliabio.bsky.social at the #SwissBiotechDay 2025 in Basel and discussing drug target ID/validation powered by single-cell CRISPR screens in primary human cells!

🎯 Explore Myllia's platform: myllia.com
📩 Contact: info@myllia.com

#TeamMyllia #CRISPR #scRNASeq
April 15, 2025 at 3:04 PM
mylliabio.bsky.social
Teamwork makes the dreamwork! Every individual at Myllia plays an important role in advancing science and helping CROP-Seq data reach companies working on target discovery. Today, we’re proud to highlight the employees that are part of #TeamMyllia
🔗 myllia.com/about-us/
Team Myllia employees
July 22, 2026 at 2:59 PM
mylliabio.bsky.social
🧬 Meet #TeamMyllia

Our mission is to accelerate drug discovery through high-content CRISPR screening:

- 150+ CRISPR screens in cell lines and primary cells
- 35+ collaborative projects worldwide
- End-to-end workflows from screening to bioinformatics

www.myllia.com
At Myllia, our mission is to accelerate drug discovery through high-content CRISPR screening. Since our founding in 2018 by Thomas Moser (CEO), Tilmann Buerckstuemmer (CSO), and Christoph Bock (Scientific Advisor), we have partnered with biotech and pharmaceutical companies globally to support their drug discovery programmes. We are committed to identifying and validating drug targets through CRISPR screening in the most biologically relevant cellular models:   - 150+ CRISPR screens in cell lines and primary human cells - 35+ collaborative projects worldwide - End-to-end workflows from experimental screening to computational analysis Our platform integrates multiple CRISPR modalities with primary human cell types, combined with high-content readouts such as single-cell RNA-Seq, CITE-Seq, FACS, and fitness assays. 👇 Are you curious how functional genomics can transform drug discovery? Follow us for updates & insights, and check out www.myllia.com
August 21, 2025 at 11:21 AM